Results 91 to 100 of about 542,310 (274)

Toward Fit‐for‐Purpose Data for Drug Assessment in Non‐small Cell Lung Cancer: A Core Dataset

open access: yesClinical Pharmacology &Therapeutics, EarlyView.
Considering the high unmet medical need in people with non‐small cell lung cancer (NSCLC), the drug assessment for targeted therapies often rely on small populations and single‐arm trials, challenging the evaluation by regulatory authorities, health technology assessment bodies (HTAb), and clinicians.
Geeske F. Grit   +6 more
wiley   +1 more source

Proton beam therapy in paediatric cancer: Anticipating the opening of the Australian Bragg Centre for Proton Therapy and Research

open access: yesJournal of Medical Imaging and Radiation Oncology, EarlyView., 2023
Summary Proton Beam Therapy (PBT) has the potential to improve paediatric cancer care by reducing radiation exposure and thus long‐term toxicities. Ethical concerns and debates surrounding the treatment, such as eligibility and accessibility, are ongoing in Australia. The Australian Bragg Centre for Proton Therapy and Research (ABCPTR) (named after Sir
Jeremy Khong   +10 more
wiley   +1 more source

Soft Palate Ulceration and Multiple Cranial Nerve Palsies

open access: yes, 1979
Cranial nerve palsies; Ulceration of the soft palateA 21-year old male with multiple cranial nerve palsies.ThrombocytopeniaXRT; Immunosupressive agents ...
Marilyn Kay, MD; John McCrary, MD
core  

The association between neural crest‐derived glia and melanocyte lineages throughout development and disease

open access: yesDevelopmental Dynamics, EarlyView.
Abstract Neural crest cells are a transient cell population that emerges from the dorsal neural tube during neurulation and migrates extensively throughout the embryo. Among their diverse derivatives, glial cells (such as Schwann and satellite ganglionic cells) and melanocytes represent two major lineages. In vitro studies suggested they share a common
Chaya Kalcheim
wiley   +1 more source

Multiple Cranial Nerve Palsies

open access: yes, 1981
Loss of vision; Cranial nerve paresisCase 1: A 69-year old male with left facial weakness and subsequent left craninal nerve deficits. Previous history significant for MI.
James B. MacLean, MD
core  

Evidence for functional convergence between LZTS2 and DYRK1A during craniofacial development

open access: yesDevelopmental Dynamics, EarlyView.
Abstract Background Precise control of DYRK1A dosage is essential for embryonic development, including craniofacial morphogenesis. While LZTS2 is among the most consistently identified DYRK1A‐interacting proteins, its roles in embryonic development remain incompletely understood, and its potential contribution to craniofacial development has not been ...
Nicole Cheng   +3 more
wiley   +1 more source

Low‐intensity focused ultrasound neuromodulation for drug‐resistant epilepsy: A randomized, sham‐controlled crossover trial

open access: yesEpilepsia, EarlyView.
Abstract Objective This study was undertaken to evaluate the safety, feasibility, and efficacy of low‐intensity focused ultrasound (LIFU) as a noninvasive neuromodulation technique in patients with drug‐resistant epilepsy (DRE). Methods In this pilot, single‐blind, randomized sham‐controlled crossover trial, 12 patients with DRE underwent both LIFU and
Chien‐Chen Chou   +8 more
wiley   +1 more source

Multicranial neuropathy in reactivated varicella zoster virus infection - a case report

open access: yesБългарска неврология
Introduction: Herpes zoster typically presents with dermatomal rash and radicular pain. Although rare, but it can cause various neurological complications such as meningitis, encephalitis, myelitis, cerebral angiitis, subacute amyotrophy and cranial ...
Garima Shant, Deepak Jain, Manisha Dolia
doaj   +1 more source

Sternocleidomastoid testing, cranial nerve XI

open access: yes, 2021
Testing sternocleidomastoid (SCM) cranial nerve XI-examiner asks patient to actively turn head to one side and then puts hand on side of face and tries to push face back to midlinehttps://ir.lib.uwo.ca/clinicalskills_neuroexam/1559/thumbnail ...
Clinical Neurological Sciences, Schulich School of Medicine and Dentistry
core  

Perils and progress in epilepsy surgery utilization: Twenty‐five years later

open access: yesEpilepsia, EarlyView.
Abstract More than 25 years have passed since the first randomized controlled trial (RCT) established that surgery is superior to continued anti‐seizure medication (ASM) for drug‐resistant temporal lobe epilepsy, and nearly as long since a joint practice parameter urged that appropriate surgical candidates be referred to a specialized center for ...
Dario J. Englot
wiley   +1 more source

Home - About - Disclaimer - Privacy